Navigation Links
Bluemetal Architects appoints David Le Penske as Vice President of Health & Life Sciences
Date:1/30/2013

roups and organizations.  As co-founder and CEO, he led AccelMD's business growth strategy and was responsible for driving revenue and expanding service solution offerings including a distribution agreement with Manulife Financial Corporation's Group and Individual Benefits divisions. He and his partners sold the company to WorldCare of Boston, MA in 2012.

"In my view, there has simply never been a greater time in the history of medicine where technology can make such a profoundly positive impact," said Mr. Le Penske .  "Similar to financial services a decade ago, healthcare data and insights should be securely and readily accessible to approved users on any device that connects to the internet, and modern applications will play a pivotal role in making our health easy to understand, self-serve and more accountably managed."

"David has a tremendous vision for the future of Health Care, where heterogeneous data can be combined into a highly secure cloud-based "big data" asset that can be connected to modernized workflows and applications to facilitate collaboration across the continuum of care," said Todd Bremner , CEO and Chief Architect of BlueMetal Architects. "BlueMetal's design and delivery capabilities will speed the impact of David's vision to enable research-based medicine to become a more connected and personalized evidence-based care."

In the coming year Mr. Le Penske will work with BlueMetal's practice teams and General Managers in Boston, New York, and Chicago to drive strategy and execution focused on winning key projects to advance the state of the art in Health and Life Sciences by increasing client, strategic partner and project revenue growth and market share across the Health and Life Sciences vertical.



Media C
'/>"/>

SOURCE BlueMetal Architects
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
2. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
3. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
4. The American Society for Microbiology honors David Tobin
5. Environmental activist David Suzuki is fifth recipient of CWRU’s Inamori Ethics Prize
6. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
7. UCLAs Yi Tang receives Presidential Green Chemistry Challenge Award from EPA
8. NASA Goddard scientist receives Presidential Early Career Award
9. ONR-funded young innovators recognized by President
10. President Obama honors MU researcher with National Medal of Science
11. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , Jan. 28, 2015 Research and ... the addition of the "Global Biometrics Market ... Regions and Countries " report to their offering. ... Asia-Pacific is anticipated to ... 2015, owing to increasing government spending towards IT ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to ... biometrics technology is to ensure that an individual is who ... technology may make use of a person,s unique physical characteristics, ...
(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( ... launched its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz ... build of production capacity to meet customer demand. ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
Breaking Biology News(10 mins):Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased ... new research tool for cancer drug research and development companies ... Drug targets and their pathways are the ... of cancer. The Oncology Drug Pathway Analyzer from BioSeeker Group ...
... WASHINGTON, June 5, 2012  President Barack Obama has made ... security of the United States.  To ensure that the ... 6, in Washington, D.C., his administration will convene a ... to discuss the major cyber security issues affecting the ...
... Washington, DCJune 6, 2012 Anthony R. Richardson, Ph.D., Assistant ... Carolina Hill School of Medicine, has been honored with ... Awards. These awards, given annually to two young scientists ... medical microbiology and infectious diseases, are presented in memory ...
Cached Biology News:New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge 2New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge 3Jim Demitrieus, CEO of EyeLock, Invited to White House Cyber Security Event 2Jim Demitrieus, CEO of EyeLock, Invited to White House Cyber Security Event 3The American Society for Microbiology honors Anthony R. Richardson 2
(Date:3/3/2015)... BlueInGreen announces the ... sales network. The business venture will bring the ... Atlantic Provinces, exclusively through Resource Systems. , Since ... Canada’s premiere manufacturing representative firms, hosting a diverse ... and wastewater markets. More information on Resource Systems ...
(Date:3/3/2015)... March 3, 2015 Fried, Frank, Harris, Shriver ... Lewis has joined the Firm as a partner ... New York office. Mr. Lewis ... as well as other intellectual property and general litigation. ... Lewis represents both plaintiffs and defendants in a range ...
(Date:3/3/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or ... Expert Opinion on Biological Therapy , Dr. Michael ... , at the Henry Ford Hospital in ... (TB4) has the capacity to promote CNS and peripheral ... leading to neurological recovery in each case.  They pointed ...
(Date:3/3/2015)... IRVINE, Calif. , March 3, 2015 AtheroNova ... subsidiary, AtheroNova Operations, Inc., filed voluntary petitions under Chapter 11 ... Central District of California , ... 2, 2015. The Company,s Chapter 11 cases are expected to ... options, including a Bankruptcy Court supervised asset sale process, for ...
Breaking Biology Technology:BlueInGreen® Continues Canadian Expansion, Partners with Resource Systems Inc. 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4
... (GFP) in their retina cells or other tissues can ... real time computer record of movement and gene expression. ... BMC Biotechnology , will allow detailed analyses of ... Tower led a team of researchers from the University ...
... Washington Life Sciences Discovery,Fund (LSDF) has awarded nearly $4.7 ... Alliance (WAVA) and to support initial research into,three new ... the,grant is funded by Washington,s$350 million tobacco-lawsuit-settlement bonus,and provides ... , WAVA core ...
... Office has,issued Nutraceutix, Inc. a patent for BIO-tract. It ... the technology has been awarded based,on BIO-tract,s ability to ... their way to optimal release sites in the,intestinal tract. ... Nutraceutix comments: "Many years ago,we recognized the need for ...
Cached Biology Technology:Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program 2Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program 3Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program 4Probiotic Delivery Technology Awarded Third International Patent 2
... is a fluorescent counterstain which ... color. The bright blue fluorescence ... fluorochromes such as rhodamine, Cy3, ... can be used for fluorescent ...
Contact us for more information...
... Most sensitive silver stain. ... No stop baths or reversers ... lipids and polysaccharides. Linear ... to stain multiple gels per ...
... you to insert a transposable element of ... in vitro transposition. It uses TnsABC* Transposase ... DNA target. Target DNA may be a ... on your interests (6-8). If the insertion ...
Biology Products: